0001209191-15-024198.txt : 20150309 0001209191-15-024198.hdr.sgml : 20150309 20150309181737 ACCESSION NUMBER: 0001209191-15-024198 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140617 FILED AS OF DATE: 20150309 DATE AS OF CHANGE: 20150309 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NOVAVAX INC CENTRAL INDEX KEY: 0001000694 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222816046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 240-268-2000 MAIL ADDRESS: STREET 1: 20 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCMANUS MICHAEL A JR CENTRAL INDEX KEY: 0001051997 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26770 FILM NUMBER: 15686497 MAIL ADDRESS: STREET 1: 241-02 NORTHERN BLVD CITY: DOUGLASTON STATE: NY ZIP: 11362 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-06-17 0 0001000694 NOVAVAX INC NVAX 0001051997 MCMANUS MICHAEL A JR C/O NOVAVAX, INC. 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 1 0 0 0 Common Stock 2014-06-17 4 M 0 15000 0.56 A 137590 D Common Stock 2014-06-17 4 M 0 30000 1.28 A 167590 D Stock Option (Right to buy) 0.56 2014-06-17 4 M 0 15000 0.00 D 2009-09-05 2019-03-05 Common Stock 15000 0 D Stock Option (Right to buy) 1.28 2014-06-17 4 M 0 30000 0.00 D 2012-09-01 2022-03-01 Common Stock 30000 0 D Stock Option (Right to buy) 8.94 2015-03-05 4 A 0 40000 0.00 A 2015-09-05 2025-03-05 Common Stock 40000 40000 D This option grant was approved by a committee of Novavax's board of directors on March 5, 2015, subject to shareholder approval of the Novavax, Inc. 2015 Stock Incentive Plan. /s/ John A. Herrmann III, Attorney-in-Fact 2015-03-09